Most cited papers from Sanofi (France)

Sanofi (France)

What are the most cited papers from Sanofi (France)?

The most cited paper from Sanofi (France) is "Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)" (Daniel J. Klionsky et al., 2016), with 6,023 citations. Next come "Proposed minimum reporting standards for chemical analysis" (5,359) and "Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer" (3,709).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 992 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors	2 Jan 2016	6,023
2	Proposed minimum reporting standards for chemical analysis Lloyd W. Sumner et al. · Metabolomics Open access	11 Sep 2007	5,359
3	Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf et al. · New England Journal of Medicine Open access	2 Jun 2004	3,709
4	Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome Gregory G. Schwartz et al. · New England Journal of Medicine Open access	7 Nov 2018	3,654
5	Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial Johann Sebastian De Bono, Stéphane Marie. Oudard, Mustafa Özgüroğlu et al. · The Lancet	Oct 2010	3,328
6	Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia Roger A. Fielding et al. · Journal of the American Medical Directors Association Open access	5 Mar 2011	3,319
7	Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand Supachai Rerks‐Ngarm et al. · New England Journal of Medicine Open access	20 Oct 2009	3,067
8	International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors Allyn C. Howlett, F. Barth, T.I. Bonner et al. · Pharmacological Reviews	Jun 2002	2,839
9	Adjuvant Trastuzumab in HER2-Positive Breast Cancer Dennis J. Slamon et al. · New England Journal of Medicine Open access	5 Oct 2011	2,803
10	Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors	2 Jan 2021	2,743
11	New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics Open access1,266 authors	Apr 2022	2,608
12	Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Peter Carmeliet, Yuval Dor, Jean-Marc Herbert et al. · Nature	30 Jul 1998	2,510
13	Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Marc Alan Pfeffer, Brian Claggett, Rafael Ugarriza Díaz et al. · New England Journal of Medicine Open access	2 Dec 2015	2,382
14	Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events Jennifer G. Robinson, Michel Farnier, Michel Krempf et al. · New England Journal of Medicine Open access	15 Mar 2015	2,316
15	p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development Annie Yang, Ronen Schweitzer, Deqin Sun et al. · Nature	Apr 1999	2,264
16	Medication Compliance and Persistence: Terminology and Definitions Joyce A. Cramer, Anuja Nidumolu Roy, Anita D. Burrell et al. · Value in Health Open access	26 Jun 2007	2,235
17	CHEM21 selection guide of classical- and less classical-solvents Denis Prat, A.S. Wells, John D. Hayler et al. · Green Chemistry Open access	13 Aug 2015	2,229
18	Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications L. Harivardhan Reddy, José Luis Arias, Julien Nicolas et al. · Chemical Reviews Review	9 Oct 2012	2,111
19	Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis Eric Lawrence Simpson et al. · New England Journal of Medicine Open access	Oct 2016	2,101
20	Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Jonathan Kocarnik et al. · JAMA Oncology Open access601 authors	30 Dec 2021	2,100
21	p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities Annie Yang, Mourad Kaghad, Yunmei Wang et al. · Molecular Cell Open access	Sep 1998	2,092
22	Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals Harry M. Olson, Graham R. Betton, Denise E. Robinson et al. · Regulatory Toxicology and Pharmacology	Aug 2000	2,056
23	Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction Barry M. Massie, Peter E. Carson, John J.V. McMurray et al. · New England Journal of Medicine Open access	11 Nov 2008	1,969
24	Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor Jean‐Claude Meunier, Catherine Mollereau, Lawrence Toll et al. · Nature	12 Oct 1995	1,919
25	Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine Timo Vesikari et al. · New England Journal of Medicine Open access	4 Jan 2006	1,890
26	Estimating the Global Burden of Endemic Canine Rabies Katie Hampson et al. · PLoS neglected tropical diseases Open access	16 Apr 2015	1,859
27	Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations Sylvaine Galiègue, Sophie Mary, Jean Marchand et al. · European Journal of Biochemistry Open access	Aug 1995	1,769
28	SR141716A, a potent and selective antagonist of the brain cannabinoid receptor Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters Open access	22 Aug 1994	1,765
29	Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer Jan Baptist Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine Open access	24 Oct 2007	1,726
30	Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer Marshall R. Posner et al. · New England Journal of Medicine Open access	24 Oct 2007	1,713
31	Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Peter Carmeliet et al. · Nature Medicine Open access	May 2001	1,688
32	Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers Mourad Kaghad, H Bonnet, Annie Yang et al. · Cell Open access	Aug 1997	1,645
33	Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials Naveed A. Sattar, Matthew M.Y. Lee, Søren Lund Kristensen et al. · The Lancet Diabetes & Endocrinology ReviewOpen access	20 Aug 2021	1,590
34	Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials Claus Bachert et al. · The Lancet	19 Sep 2019	1,564
35	Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species Rapolas Žilionis, Camilla Engblom, Christina Pfirschke et al. · Immunity Open access	9 Apr 2019	1,550
36	Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study Alexander T. Cohen, Victor F. Tapson, Jean‐François Bergmann et al. · The Lancet Open access	Feb 2008	1,510
37	Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy Cécile Delettre, Guy Lenaers, Jean‐Michel Griffoin et al. · Nature Genetics	Oct 2000	1,454
38	Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton et al. · New England Journal of Medicine	9 Jul 2014	1,426
39	The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods Barbara Zdrazil, Eloy Félix, Fiona M. I. Hunter et al. · Nucleic Acids Research Open access	23 Oct 2023	1,423
40	Impact of high-throughput screening in biomedical research Ricardo Macarrón, Martyn N. Banks, Dejan Bojanic et al. · Nature Reviews Drug Discovery Review	Mar 2011	1,406
41	Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen Eric Van Cutsem, Josep M. Tabernero, Radek Lakomý et al. · Journal of Clinical Oncology	4 Sep 2012	1,403
42	Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology	14 Dec 2017	1,375
43	Dupilumab in Persistent Asthma with Elevated Eosinophil Levels Sally E. Wenzel, Linda Ford, David S. Pearlman et al. · New England Journal of Medicine Open access	21 May 2013	1,329
44	Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis Peter Carmeliet et al. · Cell Open access	Jul 1999	1,295
45	Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial Andrew Blauvelt et al. · The Lancet Open access	4 May 2017	1,269
46	In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis Jorge Rosenfeld, Joël Capdevielle, Jean Claude Guillemot et al. · Analytical Biochemistry	May 1992	1,254
47	Chelerythrine is a potent and specific inhibitor of protein kinase C Jean‐Marc Herbert, Jean‐Michel Augereau, J. Gleye et al. · Biochemical and Biophysical Research Communications	Nov 1990	1,210
48	Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Jose Maria Polo, Susanna X. Liu, María E. Figueroa et al. · Nature Biotechnology Open access	19 Jul 2010	1,198
49	Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans Troy D. Querec, Rama S. Akondy, Eva K. Lee et al. · Nature Immunology Open access	23 Nov 2008	1,142
50	Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation Stefan Hans Hohnloser, Harry J.G.M. Crijns, Martin van Eickels et al. · New England Journal of Medicine Open access	11 Feb 2009	1,136

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.